
Francois P. Vandervegt
Examiner (ID: 18174)
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644, 1816, 1621 |
| Total Applications | 534 |
| Issued Applications | 281 |
| Pending Applications | 89 |
| Abandoned Applications | 164 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 10/018314 | Structure-based design of compounds that inhibit detrimental cytotoxic t lymphocyte responses | May 21, 2002 | Abandoned |
Array
(
[id] => 6110438
[patent_doc_number] => 20020172681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Modulating Th2 cell levels via vMIP-I/CCR8 interaction'
[patent_app_type] => new
[patent_app_number] => 10/144883
[patent_app_country] => US
[patent_app_date] => 2002-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9343
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20020172681.pdf
[firstpage_image] =>[orig_patent_app_number] => 10144883
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/144883 | Modulating Th2 cell levels via vMIP-I/CCR8 interaction | May 13, 2002 | Abandoned |
Array
(
[id] => 6829865
[patent_doc_number] => 20030180923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/139980
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63506
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180923.pdf
[firstpage_image] =>[orig_patent_app_number] => 10139980
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/139980 | PRO4395 antibodies | May 5, 2002 | Issued |
Array
(
[id] => 7405637
[patent_doc_number] => 20040105862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Human TIMP-1 antibodies'
[patent_app_type] => new
[patent_app_number] => 10/128520
[patent_app_country] => US
[patent_app_date] => 2002-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18978
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20040105862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10128520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/128520 | Human TIMP-1 antibodies | Apr 23, 2002 | Issued |
Array
(
[id] => 408207
[patent_doc_number] => 07285525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-23
[patent_title] => 'Suppression of immune response via inhibition of cathepsin S'
[patent_app_type] => utility
[patent_app_number] => 10/126223
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12457
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/285/07285525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10126223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/126223 | Suppression of immune response via inhibition of cathepsin S | Apr 18, 2002 | Issued |
Array
(
[id] => 6821579
[patent_doc_number] => 20030219740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'DNA sequences isolated from human colonic epithelial cells'
[patent_app_type] => new
[patent_app_number] => 10/089887
[patent_app_country] => US
[patent_app_date] => 2002-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44943
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10089887
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/089887 | DNA sequences isolated from human colonic epithelial cells | Mar 28, 2002 | Abandoned |
Array
(
[id] => 5786400
[patent_doc_number] => 20020160019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Identification of broadly reactive DR restricted epitopes'
[patent_app_type] => new
[patent_app_number] => 10/103395
[patent_app_country] => US
[patent_app_date] => 2002-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 8896
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160019.pdf
[firstpage_image] =>[orig_patent_app_number] => 10103395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/103395 | Identification of broadly reactive DR restricted epitopes | Mar 19, 2002 | Abandoned |
Array
(
[id] => 645647
[patent_doc_number] => 07119170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-10
[patent_title] => 'Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases'
[patent_app_type] => utility
[patent_app_number] => 10/092404
[patent_app_country] => US
[patent_app_date] => 2002-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6996
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/119/07119170.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092404
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092404 | Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases | Mar 3, 2002 | Issued |
Array
(
[id] => 6647395
[patent_doc_number] => 20030104472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Antibody specifically binding human pinch protein homolog'
[patent_app_type] => new
[patent_app_number] => 10/092066
[patent_app_country] => US
[patent_app_date] => 2002-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16088
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104472.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092066
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092066 | Antibody specifically binding human pinch protein homolog | Mar 3, 2002 | Abandoned |
Array
(
[id] => 6476426
[patent_doc_number] => 20020151707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Immune mediators and related methods'
[patent_app_type] => new
[patent_app_number] => 10/081281
[patent_app_country] => US
[patent_app_date] => 2002-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30035
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151707.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081281
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081281 | Immune mediators and related methods | Feb 19, 2002 | Abandoned |
Array
(
[id] => 5907904
[patent_doc_number] => 20020142944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Treatment of ocular disorders'
[patent_app_type] => new
[patent_app_number] => 10/079931
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3396
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142944.pdf
[firstpage_image] =>[orig_patent_app_number] => 10079931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/079931 | Treatment of ocular disorders | Feb 18, 2002 | Abandoned |
Array
(
[id] => 7202801
[patent_doc_number] => 20040086960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same'
[patent_app_type] => new
[patent_app_number] => 10/075257
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14528
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086960.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075257
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075257 | Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same | Feb 14, 2002 | Abandoned |
Array
(
[id] => 6258686
[patent_doc_number] => 20020187147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Antigen specific recombinant MHC class II molecules and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/074257
[patent_app_country] => US
[patent_app_date] => 2002-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 14455
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10074257
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/074257 | Antigen specific recombinant MHC class II molecules and methods of use | Feb 13, 2002 | Abandoned |
Array
(
[id] => 830284
[patent_doc_number] => 07399838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-15
[patent_title] => 'Single chain class I major histo-compatibility complexes'
[patent_app_type] => utility
[patent_app_number] => 10/073300
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 14883
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/399/07399838.pdf
[firstpage_image] =>[orig_patent_app_number] => 10073300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/073300 | Single chain class I major histo-compatibility complexes | Feb 12, 2002 | Issued |
Array
(
[id] => 961211
[patent_doc_number] => 06951924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-04
[patent_title] => 'Antibodies against secreted protein HTEBYII'
[patent_app_type] => utility
[patent_app_number] => 10/058993
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 201196
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/951/06951924.pdf
[firstpage_image] =>[orig_patent_app_number] => 10058993
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/058993 | Antibodies against secreted protein HTEBYII | Jan 29, 2002 | Issued |
Array
(
[id] => 5858579
[patent_doc_number] => 20020122820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Soluble MHC artificial antigen presenting cells'
[patent_app_type] => new
[patent_app_number] => 10/050231
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6191
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20020122820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050231
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050231 | Soluble MHC artificial antigen presenting cells | Jan 15, 2002 | Abandoned |
Array
(
[id] => 6177713
[patent_doc_number] => 20020156011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Compositions and methods for the therapy and diagnosis of colon cancer'
[patent_app_type] => new
[patent_app_number] => 10/046935
[patent_app_country] => US
[patent_app_date] => 2002-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38366
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20020156011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10046935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/046935 | Compositions and methods for the therapy and diagnosis of colon cancer | Jan 14, 2002 | Abandoned |
Array
(
[id] => 6305360
[patent_doc_number] => 20020094332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Method of prophylaxis against large myocardial infractions'
[patent_app_type] => new
[patent_app_number] => 10/047608
[patent_app_country] => US
[patent_app_date] => 2002-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3830
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094332.pdf
[firstpage_image] =>[orig_patent_app_number] => 10047608
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/047608 | Method of prophylaxis against large myocardial infractions | Jan 13, 2002 | Abandoned |
Array
(
[id] => 5921759
[patent_doc_number] => 20020115157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof'
[patent_app_type] => new
[patent_app_number] => 10/045949
[patent_app_country] => US
[patent_app_date] => 2002-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18452
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115157.pdf
[firstpage_image] =>[orig_patent_app_number] => 10045949
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/045949 | Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof | Jan 10, 2002 | Issued |
| 09/913756 | Tyrosine kinase receptor epha3 antigenic peptides | Jan 4, 2002 | Abandoned |